Lymph node - An organ for T-cell activation and pathogen defense

Immunological Reviews

Volumn 271, Issue 1, 2016, Pages 200-220

  Gasteiger, Georg ^a   Ataide, Marco ^b   Kastenmüller, Wolfgang ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Dendritic cells; in vivo imaging; Infectious diseases; Lymph nodes; Macrophages; T cells

Indexed keywords

CD8 ANTIGEN; VIRUS ANTIGEN;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELLULAR IMMUNITY; HOST PATHOGEN INTERACTION; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; ANATOMY AND HISTOLOGY; ANIMAL; CELL MOTION; DENDRITIC CELL; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; LYMPH NODES; LYMPHOCYTE ACTIVATION; VIRUS DISEASES;

EID: 84963574867     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12399     Document Type: Article

References (225)

1. Adams DO. The granulomatous inflammatory response. A review. Am J Pathol 1976;84:164-192.
2. Peters NC, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 2008;321:970-974.
3. Chtanova T, et al. Dynamics of neutrophil migration in lymph nodes during infection. Immunity 2008;29:487-496.
4. Lammermann T, et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 2013;498:371-375.
5. Trueta J, Barnes JM. The rationale of complete immobilization in treatment of infected wounds. Br Med J 1940;2:46-48.
6. Bennett IL Jr, Beeson PB. Bacteremia: a consideration of some experimental and clinical aspects. Yale J Biol Med 1954;26:241-262.
7. Junt T, Scandella E, Ludewig B. Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat Rev Immunol 2008;8:764-775.
8. Onder L, et al. IL-7-producing stromal cells are critical for lymph node remodeling. Blood 2012;120:4675-4683.
9. Mueller SN, Germain RN. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 2009;9:618-629.
10. Bannard O, Horton RM, Allen CD, An J, Nagasawa T, Cyster JG. Germinal center centroblasts transition to a centrocyte phenotype according to a timed program and depend on the dark zone for effective selection. Immunity 2013;39:912-924.
11. Jarjour M, et al. Fate mapping reveals origin and dynamics of lymph node follicular dendritic cells. J Exp Med 2014;211:1109-1122.
12. Ulvmar MH, et al. The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes. Nat Immunol 2014;15:623-630.
13. Turley SJ, Fletcher AL, Elpek KG. The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat Rev Immunol 2010;10:813-825.
14. Chang JE, Turley SJ. Stromal infrastructure of the lymph node and coordination of immunity. Trends Immunol 2015;36:30-39.
15. Sixt M, et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005;22:19-29.
16. Rantakari P, et al. The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes. Nat Immunol 2015;16:386-396.
17. Acton SE, et al. Dendritic cells control fibroblastic reticular network tension and lymph node expansion. Nature 2014;514:498-502.
18. Astarita JL, et al. The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture. Nat Immunol 2015;16:75-84.
19. Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012;30:1-22.
20. Belz GT, Nutt SL. Transcriptional programming of the dendritic cell network. Nat Rev Immunol 2012;12:101-113.
21. Paul F, Amit I. Plasticity in the transcriptional and epigenetic circuits regulating dendritic cell lineage specification and function. Curr Opin Immunol 2014;30:1-8.
22. Iannacone M, et al. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 2010;465:1079-1083.
23. Honke N, et al. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol 2012;13:51-57.
24. Moseman EA, et al. B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity. Immunity 2012;36:415-426.
25. Harwood NE, Batista FD. Early events in B cell activation. Annu Rev Immunol 2010;28:185-210.
26. Qi H, Kastenmuller W, Germain RN. Spatiotemporal basis of innate and adaptive immunity in secondary lymphoid tissue. Annu Rev Cell Dev Biol 2014;30:141-167.
27. Gaya M, et al. Host response. Inflammation-induced disruption of SCS macrophages impairs B cell responses to secondary infection. Science 2015;347:667-672.
28. Goubau D, Deddouche S, Reis e Sousa C. Cytosolic sensing of viruses. Immunity 2013;38:855-869.
29. Junt T, Barchet W. Translating nucleic acid-sensing pathways into therapies. Nat Rev Immunol 2015;15:529-544.
30. Sancho D, Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 2012;30:491-529.
31. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34:637-650.
32. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009;27:229-265.
33. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417-426.
34. Franklin BS, et al. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat Immunol 2014;15:727-737.
35. Baroja-Mazo A, et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 2014;15:738-748.
36. Kupz A, et al. NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8(+) T cells. Nat Immunol 2012;13:162-169.
37. Soudja SM, Ruiz AL, Marie JC, Lauvau G. Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 2012;37:549-562.
38. Kastenmuller W, Torabi-Parizi P, Subramanian N, Lammermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012;150:1235-1248.
39. + T cell responses in the lymph node. Immunity 2013;38:502-513.
40. Schenkel JM, Fraser KA, Masopust D. Cutting edge: resident memory CD8 T cells occupy frontline niches in secondary lymphoid organs. J Immunol 2014;192:2961-2964.
41. Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 2009;10:524-530.
42. + T cells are resident in normal skin. J Immunol 2006;176:4431-4439.
43. Wakim LM, Woodward-Davis A, Bevan MJ. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci USA 2010;107:17872-17879.
44. Ariotti S, et al. T cell memory. Skin-resident memory CD8(+) T cells trigger a state of tissue-wide pathogen alert. Science 2014;346:101-105.
45. Schenkel JM, Fraser KA, Beura LK, Pauken KE, Vezys V, Masopust D. T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science 2014;346:98-101.
46. Schenkel JM, Fraser KA, Vezys V, Masopust D. Sensing and alarm function of resident memory CD8(+) T cells. Nat Immunol 2013;14:509-513.
47. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003;3:867-878.
48. Bajenoff M, et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006;25:989-1001.
49. Cyster JG, Schwab SR. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol 2012;30:69-94.
50. + T cells. Proc Natl Acad Sci USA 2012;109:18036-18041.
51. Badovinac VP, Haring JS, Harty JT. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 2007;26:827-841.
52. Yu W, et al. Clonal deletion prunes but does not eliminate self-specific alphabeta CD8(+) T lymphocytes. Immunity 2015;42:929-941.
53. + T cells in response to infection is markedly efficient. Science 2009;325:1265-1269.
54. Bottcher JP, et al. Functional classification of memory CD8(+) T cells by CX3CR1 expression. Nat Commun 2015;6:8306.
55. Eickhoff S, et al. Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell 2015;162:1322-1337.
56. Vander Lugt B, et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol 2014;15:161-167.
57. Ballesteros-Tato A, Leon B, Lund FE, Randall TD. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol 2010;11:216-224.
58. Miller MJ, Wei SH, Parker I, Cahalan MD. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002;296:1869-1873.
59. + T cell priming by dendritic cells in intact lymph nodes. Nat Immunol 2003;4:579-585.
60. Stoll S, Delon J, Brotz TM, Germain RN. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 2002;296:1873-1876.
61. Miller MJ, Wei SH, Cahalan MD, Parker I. Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc Natl Acad Sci USA 2003;100:2604-2609.
62. Bajenoff M, Egen JG, Qi H, Huang AY, Castellino F, Germain RN. Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node. Trends Immunol 2007;28:346-352.
63. Schumann K, et al. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 2010;32:703-713.
64. Mempel TR, Henrickson SE, Von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004;427:154-159.
65. + T cell cross-priming. J Immunol 2008;181:3067-3076.
66. Inaba K, et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180:1849-1860.
67. De Smedt T, et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996;184:1413-1424.
68. Ohl L, et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004;21:279-288.
69. Weber M, et al. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 2013;339:328-332.
70. Katakai T, Hara T, Lee JH, Gonda H, Sugai M, Shimizu A. A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int Immunol 2004;16:1133-1142.
71. Bajenoff M, Granjeaud S, Guerder S. The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation. J Exp Med 2003;198:715-724.
72. Allenspach EJ, Lemos MP, Porrett PM, Turka LA, Laufer TM. Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. Immunity 2008;29:795-806.
73. Itano AA, et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003;19:47-57.
74. Hor JL, Whitney PG, Zaid A, Brooks AG, Heath WR, Mueller SN. Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4(+) and CD8(+) T cell activation to localized viral infection. Immunity 2015;43:554-565.
75. Allan RS, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006;25:153-162.
76. Anandasabapathy N, et al. Classical Flt3L-dependent dendritic cells control immunity to protein vaccine. J Exp Med 2014;211:1875-1891.
77. Gerner MY, Torabi-Parizi P, Germain RN. Strategically localized dendritic cells promote rapid T cell responses to lymph-borne particulate antigens. Immunity 2015;42:172-185.
78. + macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells. Proc Natl Acad Sci USA 2015;112:5461-5466.
79. Schraml BU, et al. Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell 2013;154:843-858.
80. + T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol 2008;9:155-165.
81. + T cell selection of optimal lymph node antigen presenting cells. J Exp Med 2011;208:2511-2524.
82. Sung JH, et al. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 2012;150:1249-1263.
83. Lavin Y, et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 2014;159:1312-1326.
84. + T cells. Nat Immunol 2007;8:1060-1066.
85. Gerard A, et al. Detection of rare antigen-presenting cells through T cell-intrinsic meandering motility, mediated by Myo1 g. Cell 2014;158:492-505.
86. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-89.
87. Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976;143:1283-1288.
88. Freigang S, Egger D, Bienz K, Hengartner H, Zinkernagel RM. Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming. Proc Natl Acad Sci USA 2003;100:13477-13482.
89. Ochsenbein AF, et al. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 2001;411:1058-1064.
90. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997;186:239-245.
91. Zehner M, et al. The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8(+) T cells. Immunity 2015;42:850-863.
92. Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007;316:612-616.
93. Cebrian I, et al. Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell 2011;147:1355-1368.
94. Savina A, et al. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. Immunity 2009;30:544-555.
95. Samie M, Cresswell P. The transcription factor TFEB acts as a molecular switch that regulates exogenous antigen-presentation pathways. Nat Immunol 2015;16:729-736.
96. Yatim N, et al. RIPK1 and NF-kappaB signaling in dying cells determines cross-priming of CD8(+) T cells. Science 2015;350:328-334.
97. + dendritic cells in cytotoxic T cell immunity. Science 2008;322:1097-1100.
98. Yamazaki C, et al. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1. J Immunol 2013;190:6071-6082.
99. Probst HC, van den Broek M. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J Immunol 2005;174:3920-3924.
100. + T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation. J Immunol 2013;190:2767-2777.
101. Nopora K, et al. MHC class I cross-presentation by dendritic cells counteracts viral immune evasion. Front Immunol 2012;3:348.
102. Kastenmuller W, et al. Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity. Virology 2006;350:276-288.
103. Drillien R, Spehner D, Bohbot A, Hanau D. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 2000;268:471-481.
104. Engelmayer J, et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Immunol 1999;163:6762-6768.
105. Gasteiger G, Kastenmuller W, Ljapoci R, Sutter G, Drexler I. Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines. J Virol 2007;81:11925-11936.
106. Schmidt FI, et al. Vaccinia virus entry is followed by core activation and proteasome-mediated release of the immunomodulatory effector VH1 from lateral bodies. Cell Rep 2013;4:464-476.
107. Mercer J, et al. RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. Cell Rep 2012;2:1036-1047.
108. Townsend A, et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 1988;168:1211-1224.
109. + T cells shapes the immunodominance hierarchy during boost vaccination. J Exp Med 2007;204:2187-2198.
110. Gutierrez-Martinez E, et al. Cross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets. Front Immunol 2015;6:363.
111. Adiko AC, Babdor J, Gutierrez-Martinez E, Guermonprez P, Saveanu L. Intracellular transport routes for MHC I and their relevance for antigen cross-presentation. Front Immunol 2015;6:335.
112. Kurts C, Robinson BW, Knolle PA. Cross-priming in health and disease. Nat Rev Immunol 2010;10:403-414.
113. + T cell cross-priming via transfer of proteasome substrates. Science 2004;304:1318-1321.
114. Wolkers MC, Brouwenstijn N, Bakker AH, Toebes M, Schumacher TN. Antigen bias in T cell cross-priming. Science 2004;304:1314-1317.
115. Freigang S, et al. A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8(+) T cell responses. Proc Natl Acad Sci USA 2007;104:13426-13431.
116. Lev A, et al. The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity 2008;28:787-798.
117. Giodini A, Rahner C, Cresswell P. Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells. Proc Natl Acad Sci USA 2009;106:3324-3329.
118. + T cells by infected dendritic cells in vivo. Nat Immunol 2002;3:265-271.
119. + T cell immunodominance in primary and secondary influenza virus infections. J Exp Med 2003;198:399-410.
120. Crowe SR, Miller SC, Woodland DL. Identification of protective and non-protective T cell epitopes in influenza. Vaccine 2006;24:452-456.
121. Holtappels R, et al. Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med 2004;199:131-136.
122. Kedl RM, Kappler JW, Marrack P. Epitope dominance, competition and T cell affinity maturation. Curr Opin Immunol 2003;15:120-127.
123. Probst HC, Dumrese T, van den Broek MF. Cutting edge: competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses. J Immunol 2002;168:5387-5391.
124. Kedl RM, et al. T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med 2000;192:1105-1113.
125. Probst HC, et al. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J Immunol 2003;171:5415-5422.
126. + T cell response. PLoS Pathog 2010;6:e1000768.
127. Iborra S, Izquierdo HM, Martinez-Lopez M, Blanco-Menendez N, Reis e Sousa C, Sancho D. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest 2012;122:1628-1643.
128. Wong P, Pamer EG. Feedback regulation of pathogen-specific T cell priming. Immunity 2003;18:499-511.
129. + T cells enter reactive lymph nodes and kill dendritic cells. Nat Immunol 2007;8:743-752.
130. Keene JA, Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 1982;155:768-782.
131. + T cell responses in vivo. J Immunol 2003;171:6339-6343.
132. Wiesel M, Oxenius A. From crucial to negligible: functional CD8(+) T-cell responses and their dependence on CD4(+) T-cell help. Eur J Immunol 2012;42:1080-1088.
133. Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 2002;76:12388-12393.
134. + T lymphocytes. Nature 2003;421:852-856.
135. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003;300:337-339.
136. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003;300:339-342.
137. Okada T, et al. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol 2005;3:e150.
138. + T cells in primary and secondary responses. Proc Natl Acad Sci USA 2010;107:193-198.
139. Feau S, Arens R, Togher S, Schoenberger SP. Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat Immunol 2011;12:908-913.
140. + T cell help. J Exp Med 1997;186:65-70.
141. Cassell D, Forman J. Linked recognition of helper and cytotoxic antigenic determinants for the generation of cytotoxic T lymphocytes. Ann N Y Acad Sci 1988;532:51-60.
142. Mitchison NA, O'Malley C. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur J Immunol 1987;17:1579-1583.
143. + T-helper and a T-killer cell. Nature 1998;393:474-478.
144. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998;393:478-480.
145. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998;393:480-483.
146. Feau S, Garcia Z, Arens R, Yagita H, Borst J, Schoenberger SP. The CD4(+) T-cell help signal is transmitted from APC to CD8(+) T-cells via CD27-CD70 interactions. Nat Commun 2012;3:948.
147. + T cells: when, where, and how. Annu Rev Immunol 2006;24:519-540.
148. + T cell-dendritic cell interaction. Nature 2006;440:890-895.
149. + T cell responses. Nat Immunol 2007;8:921-930.
150. Dudziak D, et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007;315:107-111.
151. Gurka S, Hartung E, Becker M, Kroczek RA. Mouse conventional dendritic cells can be universally classified based on the mutually exclusive expression of XCR1 and SIRPalpha. Front Immunol 2015;6:35.
152. van Stipdonk MJ, Lemmens EE, Schoenberger SP. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2001;2:423-429.
153. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2001;2:415-422.
154. Bevan MJ, Fink PJ. The CD8 response on autopilot. Nat Immunol 2001;2:381-382.
155. + T cell response. J Exp Med 2006;203:2135-2143.
156. Henrickson SE, et al. Antigen availability determines CD8(+) T cell-dendritic cell interaction kinetics and memory fate decisions. Immunity 2013;39:496-507.
157. Kurachi M, et al. Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration. J Exp Med 2011;208:1605-1620.
158. Kohlmeier JE, et al. Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infection. J Exp Med 2011;208:1621-1634.
159. Hu JK, Kagari T, Clingan JM, Matloubian M. Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation. Proc Natl Acad Sci USA 2011;108:E118-E127.
160. + T cell effector pool size via IL-2 restriction. J Immunol 2011;187:3186-3197.
161. + T-cell effector differentiation by modulating IL-2 homeostasis. Proc Natl Acad Sci USA 2011;108:7529-7534.
162. Laidlaw BJ, et al. Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells. Nat Immunol 2015;16:871-879.
163. + T cell responses and promote memory. Science 2012;338:532-536.
164. Germain RN. Special regulatory T-cell review: a rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm. Immunology 2008;123:20-27.
165. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012;30:531-564.
166. Veiga-Parga T, Sehrawat S, Rouse BT. Role of regulatory T cells during virus infection. Immunol Rev 2013;255:182-196.
167. Esensten JH, Wofsy D, Bluestone JA. Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 2009;5:560-565.
168. Burzyn D, Benoist C, Mathis D. Regulatory T cells in nonlymphoid tissues. Nat Immunol 2013;14:1007-1013.
169. Germain RN. Maintaining system homeostasis: the third law of Newtonian immunology. Nat Immunol 2012;13:902-906.
170. Loebbermann J, et al. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol 2012;5:161-172.
171. Loebbermann J, Durant L, Thornton H, Johansson C, Openshaw PJ. Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells. Proc Natl Acad Sci USA 2013;110:2987-2992.
172. Arpaia N, et al. A distinct function of regulatory T cells in tissue protection. Cell 2015;162:1078-1089.
173. Hansen DS, Schofield L. Natural regulatory T cells in malaria: host or parasite allies? PLoS Pathog 2010;6:e1000771.
174. Suvas S, Rouse BT. Treg control of antimicrobial T cell responses. Curr Opin Immunol 2006;18:344-348.
175. Kanno Y, Vahedi G, Hirahara K, Singleton K, O'Shea JJ. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 2012;30:707-731.
176. + regulatory T cells. Nat Rev Immunol 2011;11:119-130.
177. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009;10:595-602.
178. Wang Y, Su MA, Wan YY. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 2011;35:337-348.
179. Yu F, Sharma S, Edwards J, Feigenbaum L, Zhu J. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat Immunol 2015;16:197-206.
180. Rudra D, et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol 2012;13:1010-1019.
181. Chung Y, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 2011;17:983-988.
182. + follicular regulatory T cells control the germinal center response. Nat Med 2011;17:975-982.
183. + regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009;326:986-991.
184. Zheng Y, et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009;458:351-356.
185. + regulatory T cells control TH1 responses in crescentic GN. J Am Soc Nephrol 2015. pii: ASN.2015020203. [Epub ahead of print].
186. Chaudhry A, Rudensky AY. Control of inflammation by integration of environmental cues by regulatory T cells. J Clin Invest 2013;123:939-944.
187. Liu Z, Gerner MY, Van Panhuys N, Levine AG, Rudensky AY, Germain RN. Immune homeostasis enforced by co-localized effector and regulatory T cells. Nature 2015;528:225-230.
188. + regulatory T-cells and IL-2: the moirai of T-cell fates? Front Immunol 2012;3:179.
189. + regulatory T cell function. Science 2008;322:271-275.
190. Qureshi OS, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011;332:600-603.
191. + T cells. Nat Immunol 2007;8:1353-1362.
192. Feinerman O, et al. Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response. Mol Syst Biol 2010;6:437.
193. Busse D, et al. Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proc Natl Acad Sci USA 2010;107:3058-3063.
194. Reichert P, Reinhardt RL, Ingulli E, Jenkins MK. Cutting edge: in vivo identification of TCR redistribution and polarized IL-2 production by naive CD4 T cells. J Immunol 2001;166:4278-4281.
195. Hofer T, Krichevsky O, Altan-Bonnet G. Competition for IL-2 between regulatory and effector T cells to chisel immune responses. Front Immunol 2012;3:268.
196. Chang JT, Wherry EJ, Goldrath AW. Molecular regulation of effector and memory T cell differentiation. Nat Immunol 2014;15:1104-1115.
197. + T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nat Immunol 2014;15:365-372.
198. + T cell immunity. Science 2013;340:630-635.
199. Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 2010;32:79-90.
200. + T cells favors terminal-effector differentiation in vivo. Immunity 2010;32:91-103.
201. + T cell responses to influenza. J Exp Med 2013;210:1591-1601.
202. + T-cell recognition results in impaired peripheral tolerance and fatal cytotoxic T-cell mediated autoimmunity. Proc Natl Acad Sci USA 2012;109:9059-9064.
203. + regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability. Nat Commun 2014;5:3495.
204. Crouse J, Xu HC, Lang PA, Oxenius A. NK cells regulating T cell responses: mechanisms and outcome. Trends Immunol 2015;36:49-58.
205. Lee SH, Kim KS, Fodil-Cornu N, Vidal SM, Biron CA. Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J Exp Med 2009;206:2235-2251.
206. Mandaric S, et al. IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence. PLoS Pathog 2012;8:e1002846.
207. Andrews DM, et al. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J Exp Med 2010;207:1333-1343.
208. + T-cell immunity. Proc Natl Acad Sci USA 2012;109:1210-1215.
209. + T cells from NK cell cytotoxicity. Immunity 2014;40:949-960.
210. Crouse J, et al. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity 2014;40:961-973.
211. Bajenoff M, et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 2006;203:619-631.
212. Garcia Z, et al. Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles. Blood 2012;120:4744-4750.
213. + T helper 1 cell differentiation. Immunity 2012;37:1091-1103.
214. Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012;481:394-398.
215. + T cell responses during chronic viral infection to limit autoimmunity. Immunity 2014;41:646-656.
216. Peppa D, et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med 2013;210:99-114.
217. Gasteiger G, Hemmers S, Bos PD, Sun JC, Rudensky AY. IL-2-dependent adaptive control of NK cell homeostasis. J Exp Med 2013;210:1179-1187.
218. + T-cell responses to intestinal commensal bacteria. Nature 2013;498:113-117.
219. Oliphant CJ, et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014;41:283-295.
220. + T cells are required for NK cell activation in vivo upon Leishmania major infection. J Immunol 2010;185:2174-2181.
221. Gasteiger G, et al. IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. J Exp Med 2013;210:1167-1178.
222. Sitrin J, Ring A, Garcia KC, Benoist C, Mathis D. Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J Exp Med 2013;210:1153-1165.
223. Gasteiger G, Fan X, Dikiy S, Lee SY, Rudensky AY. Tissue residency of innate lymphoid cells in lymphoid and non-lymphoid organs. Science 2015;350:981-985.
224. + Th2 cell responses. J Immunol 2014;192:2442-2448.
225. Gasteiger G, Rudensky AY. Interactions between innate and adaptive lymphocytes. Nat Rev Immunol 2014;14:631-639.